Melanoma Global Clinical Trials Review, H1, 2013

GlobalData
January 14, 2013
120 Pages - SKU: GBDT4944348


Melanoma Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2013 provides data on the Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



More Oncology/Hematology reports by GlobalData

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 by GlobalData
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023SummaryBreast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers ...
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 by GlobalData
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023SummaryRenal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of ...
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 by GlobalData
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018SummaryThe competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain ...
OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 by GlobalData
OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018SummaryChronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!